Menopausal Hormone Therapy and Risk of Cholecystectomy: a Prospective Study

Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohortAmong menopausal women taking hormone replacement therapy (HRT), the risk of cholecystectomy was increased among those using oral estrogen therapy, especially oral regimens without a progestagen.
This is the finding of a prospective cohort study that assessed the use of different regimens of HRT among more than 70 000 menopausal women. Complicated gallstone disease should be added to the list of potential adverse events to be considered when balancing the benefits and risks associated with HRT, say the authors.

Read Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort

Author: DES Daughter

Activist, blogger and social media addict committed to shedding light on a global health scandal and dedicated to raise DES awareness.

2 thoughts on “Menopausal Hormone Therapy and Risk of Cholecystectomy: a Prospective Study”

Have your say! Share your views

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s